Rucaparib 300 mg Tablets
Introduction
Access to quality-assured oncology medicines is an important consideration for pharmaceutical importers, healthcare distributors, hospital procurement departments, and institutional buyers. When sourcing specialist cancer medicines internationally, buyers must evaluate product specifications, manufacturer credentials, quality documentation, regulatory status, and shipping arrangements before confirming an order.
India has an established pharmaceutical manufacturing industry and supplies finished medicines to international markets. For eligible buyers, Indian pharmaceutical suppliers may provide additional sourcing options, subject to product availability, manufacturing arrangements, and the regulatory requirements of the destination country.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, offers pharmaceutical products across multiple therapeutic categories. International buyers looking for a rucaparib 300 mg tablets exporter from India can contact the company to enquire about potential sourcing options. The exact product, manufacturer, current availability, supporting documentation, and export eligibility should be confirmed directly before placing an order.
This guide explains the key considerations involved in sourcing rucaparib 300 mg tablets, from identifying the correct formulation to evaluating suppliers, reviewing documentation, and coordinating international pharmaceutical shipments.
Key Highlights
- Generic name: Rucaparib.
- Common strength: 300 mg per tablet.
- Dosage form: Oral film-coated tablet for the referenced presentation.
- Therapeutic category: Anticancer medicine; poly (ADP-ribose) polymerase (PARP) inhibitor.
- Approved uses: Specific cancer indications, depending on the product label and destination market.
- Potential buyers: Authorised pharmaceutical importers, oncology medicine distributors, hospital procurement departments, and eligible institutional buyers.
- Essential checks: Product identity, actual manufacturer, batch documentation, shelf life, storage requirements, and regulatory approval.
- Supplier enquiry: Contact Dolphin Pharmaceuticals to confirm whether the requested product can be sourced for the intended destination.
These details are a starting point for procurement discussions. Product availability, approved indications, and export eligibility must be verified for the exact medicine and destination market.
Understanding Rucaparib 300 mg Tablets
Rucaparib is an oral anticancer medicine belonging to the PARP inhibitor class. PARP enzymes are involved in DNA repair, and inhibiting these enzymes can affect the survival of certain cancer cells.
Depending on the applicable product approval, rucaparib may be used for specific indications involving ovarian, fallopian tube, primary peritoneal, or selected prostate cancers. Eligibility can depend on factors such as cancer type, genetic findings, previous treatment, and the approved indication.
The medicine is not appropriate for every cancer patient. Its use must be determined by qualified healthcare professionals according to the applicable product information and the patient's clinical circumstances.
For pharmaceutical procurement teams, understanding the exact product is essential. The buyer should verify the active ingredient, strength, dosage form, manufacturer, packaging, and destination-market authorisation rather than relying only on a broad description such as “anticancer medicine.”
Rucaparib 300 mg Tablets: Product Details
When requesting a quotation, international pharmaceutical buyers should confirm the following details:
- Generic name: Rucaparib.
- Strength: 300 mg per tablet.
- Dosage form: Oral film-coated tablet for the referenced product.
- Therapeutic category: PARP inhibitor.
- Approved indication: Confirm against the applicable product label and destination-market approval.
- Route of administration: Oral.
- Brand name: Specify the preferred brand, if applicable.
- Manufacturer: Verify the actual manufacturer and manufacturing site.
- Packaging: Confirm the available pack size and configuration.
- Storage: Follow the approved storage instructions for the exact product supplied.
- Shelf life: Confirm the expiry date and minimum remaining shelf life required by the importer.
- Availability: Verify directly with the supplier.
- Export eligibility: Confirm for the destination country before ordering.
Indian-market product information has identified Nuparp 300 mg as a rucaparib tablet marketed by Zydus Lifesciences and manufactured by BDR Pharmaceuticals International Pvt. Ltd. This is an example of an Indian-market product, not confirmation that Dolphin Pharmaceuticals currently stocks or exports it. Buyers should independently verify the current product details and authorisations.
Why Consider a Rucaparib Supplier from India?
International pharmaceutical buyers may consider Indian suppliers as part of their sourcing strategy. However, the supplier should be evaluated on verifiable product information, manufacturer transparency, documentation, and regulatory compliance rather than country of origin alone.
1. Pharmaceutical Sourcing Options
A supplier may review a buyer's requirements and clarify whether the requested medicine can be supplied or sourced.
For an accurate enquiry, buyers should provide the required strength, preferred brand, quantity, packaging requirements, destination country, and any manufacturer preferences.
Detailed specifications help reduce product mismatches and allow the supplier to assess the request more efficiently.
2. Manufacturer Transparency
The exporter and the actual medicine manufacturer may be different organisations. Buyers should establish who manufactures the product and verify the relevant manufacturing-site details.
The manufacturer's name, product label, batch information, and supporting documentation should be consistent with the product being offered.
Where required, buyers should also verify that the manufacturer and exporter hold the authorisations relevant to the transaction.
3. Quality Documentation
Quality assurance is particularly important when sourcing prescription oncology medicines.
Depending on the product and destination requirements, buyers may request product specifications, batch information, a Certificate of Analysis, manufacturing details, and applicable quality certificates.
Documents should be reviewed for consistency and completeness before the shipment is approved.
4. International Procurement Coordination
Cross-border pharmaceutical procurement involves more than comparing unit prices. Buyers and suppliers need to coordinate quotations, payment terms, packaging, lead times, shipping arrangements, and regulatory documentation.
Written confirmation of these details helps procurement teams plan budgets and reduce misunderstandings during the transaction.
Dolphin Pharmaceuticals: Pharmaceutical Sourcing Enquiries
Dolphin Pharmaceuticals is based in Surat, Gujarat, India, and offers pharmaceutical products across multiple therapeutic categories.
For buyers searching for a rucaparib 300 mg tablets exporter from India, the company can be approached to discuss the specific product requirement. Current availability and the ability to supply a particular brand or formulation must be confirmed directly.
Before proceeding, buyers should request confirmation of:
- The exact rucaparib product and strength.
- Brand name and actual manufacturer.
- Manufacturing-site information, where applicable.
- Current availability and quotation.
- Packaging configuration and minimum order quantity, if applicable.
- Product specifications and batch documentation.
- Storage and transportation requirements.
- Destination-market registration or approval status.
- Export documentation and estimated lead time.
A general pharmaceutical portfolio does not establish that a particular oncology medicine is in stock or approved for export to a specific country. Product-specific verification should take place before an order is finalised.
How to Choose a Reliable Rucaparib Exporter
Selecting a pharmaceutical exporter requires a structured review of the supplier, the product, and the proposed transaction.
Verify Supplier Credentials
Review the supplier's legal business details, relevant licences, and role in the pharmaceutical supply chain. Establish whether the company manufactures the product, distributes it, or exports a medicine manufactured by another organisation.
Where applicable, verify the authorisations required for the manufacturer, exporter, and importing organisation.
Confirm Product Specifications
Ensure that the product matches the procurement requirement for generic name, strength, dosage form, packaging, and manufacturer.
For rucaparib, the 300 mg strength should be clearly identified on the quotation and supported by the relevant product documentation.
Review Product and Batch Documentation
Request the applicable product and batch records. Confirm that the product name, strength, manufacturer, batch number, expiry information, and other relevant details are consistent.
Resolve missing information or discrepancies before approving the shipment.
Assess Storage and Transportation
Review the manufacturer's approved storage instructions and confirm that the proposed transport arrangements are appropriate for the exact product.
The US prescribing information for Rubraca specifies storage at 20°C to 25°C, with permitted excursions from 15°C to 30°C. This is product-label information for that presentation; the approved instructions for the actual product being procured should take precedence.
Compare Complete Quotations
Compare quotations using the same product specifications and commercial terms.
Consider the unit price, quantity, packaging, remaining shelf life, payment terms, freight, insurance where applicable, documentation, and expected delivery time.
A low price alone does not establish product authenticity, quality, or regulatory eligibility.
Quality and Regulatory Documentation for Export
Documentation requirements vary according to the medicine, manufacturer, transaction, and destination-country rules. Buyers should request a product-specific checklist before confirming an order.
Commercial Documents
Common commercial documents may include:
- Proforma invoice.
- Commercial invoice.
- Packing list.
- Purchase order and agreed sales terms.
- Applicable transport documentation.
Product and Quality Documents
Depending on the transaction, buyers may need:
- Product specifications and approved product information.
- Manufacturer and manufacturing-site details.
- Batch number and expiry information.
- Certificate of Analysis, where applicable.
- Relevant manufacturing or quality certificates.
- Product registration or approval records, where required.
Regulatory Documents
Buyers should establish whether the destination country requires product registration, an import permit, importer authorisation, or other regulatory approval.
Institutional procurement programmes may also require additional supplier qualification or product quality-assurance checks.
Not every document applies to every product or destination. The required documents should be confirmed with the relevant authorities and supply-chain partners before shipment.
Regulatory Compliance for International Oncology Supply
Pharmaceutical exports and imports are governed by the applicable laws and procedures of the exporting and destination countries. A medicine available in India is not automatically authorised for import or sale in another market.
Before placing an order, buyers should verify:
- Whether the exact product is registered or otherwise authorised in the destination country.
- Whether an import permit or additional approval is required.
- Whether the importing organisation is authorised to receive and distribute the medicine.
- Which product, manufacturer, and quality documents must be submitted.
- Whether packaging and labelling comply with local requirements.
- Whether additional restrictions apply to the proposed transaction.
Buyers should also check whether the procurement programme requires a specific quality-assurance standard or an approved supplier or product list.
Regulatory verification should be completed before finalising the order or dispatching the shipment.
Storage, Packaging, and Shipment Planning
Appropriate handling helps maintain product quality throughout the supply chain.
Storage Conditions
Follow the approved storage instructions for the exact rucaparib product. Do not assume that all brands or presentations have identical requirements.
Packaging and Labelling
Confirm the pack size and packaging configuration. Ensure that product identity, strength, batch details, expiry information, and labelling meet the applicable requirements of the destination market.
Shelf-Life Management
Confirm the expiry date and the minimum remaining shelf life required by the importer.
International transit, customs clearance, and local distribution should be considered when planning the shipment.
Shipping Coordination
Agree on the shipping method, dispatch schedule, transit time, documentation responsibilities, and any special handling requirements before dispatch.
The exporter, importer, and logistics provider should coordinate to ensure that the shipment follows the product's documented requirements.
How to Request a Quotation from Dolphin Pharmaceuticals
A detailed enquiry helps the supplier assess the request and determine whether a suitable sourcing option may be available.
International buyers should provide:
- Required rucaparib strength.
- Preferred brand or manufacturer, if applicable.
- Dosage form and pack size.
- Required quantity.
- Destination country.
- Known product registration or import requirements.
- Required quality and regulatory documents.
- Preferred delivery schedule.
Request written confirmation of the exact product, manufacturer, availability, commercial terms, supporting documentation, and export eligibility.
The quotation should identify the medicine clearly so that the buyer can compare it against the original procurement specification.
Frequently Asked Questions
1. What is rucaparib 300 mg used for?
Rucaparib is a PARP inhibitor used for specific cancer indications under the applicable product approval. Approved uses vary by jurisdiction and may include selected ovarian, fallopian tube, primary peritoneal, or prostate cancers. Treatment decisions must be made by qualified healthcare professionals.
2. Is rucaparib available in India?
Indian-market product listings have identified rucaparib 300 mg tablets, including Nuparp 300. Buyers should verify current product status, manufacturer details, availability, and regulatory requirements before procurement.
3. Can rucaparib 300 mg tablets be exported from India?
International supply may be possible when the product, exporter, importer, and transaction meet the applicable requirements. Destination-market approval and export eligibility must be confirmed for the specific product.
4. Does Dolphin Pharmaceuticals currently stock rucaparib 300 mg tablets?
Current stock and sourcing availability must be confirmed directly with Dolphin Pharmaceuticals. Buyers should provide the required quantity, preferred brand, destination country, and documentation requirements.
5. Which documents should buyers request?
Depending on the product and destination, buyers may need product specifications, manufacturer details, batch information, a Certificate of Analysis where applicable, quality certificates, and relevant registration or import documents.
6. How should rucaparib tablets be stored?
Follow the approved storage instructions for the exact product supplied. The US label for Rubraca specifies controlled room-temperature storage, but the applicable instructions for the procured product should be verified.
7. Can rucaparib be supplied to every international market?
No. Product registration, import permissions, importer authorisation, and procurement requirements vary by country. Buyers should verify all applicable requirements before confirming an order.
Conclusion
Finding a dependable rucaparib 300 mg tablets exporter from India requires careful evaluation of product specifications, manufacturer credentials, quality documentation, regulatory compliance, and international shipping arrangements.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be contacted to discuss potential sourcing requirements for rucaparib 300 mg tablets. Buyers should confirm the exact product, manufacturer, current availability, supporting documents, commercial terms, and destination-market eligibility before finalising an order.
For pharmaceutical importers, oncology medicine distributors, and institutional procurement teams, a clear product specification and documented supplier review can help support a more transparent procurement process.
Planning a rucaparib procurement enquiry? Prepare the required strength, quantity, preferred manufacturer, destination country, and documentation requirements so that Dolphin Pharmaceuticals can assess the request and clarify the next steps.
Disclaimer: This article is intended for pharmaceutical procurement and general informational purposes only. Rucaparib is a prescription anticancer medicine. Treatment decisions must be made by qualified healthcare professionals, and products should be sourced and distributed through authorised pharmaceutical channels.
My Company Name - Dolphin Pharmaceuticals
My Website - https://www.dolphinpharma.in/